Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.

Baldin C, Soliman SSM, Jeon HH, Alkhazraji S, Gebremariam T, Gu Y, Bruno VM, Cornely OA, Leather HL, Sugrue MW, Wingard JR, Stevens DA, Edwards JE Jr, Ibrahim AS.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00746-18. doi: 10.1128/JCM.00746-18. Print 2018 Oct.

PMID:
30068535
2.

The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef EG, Alkhazraji S, Yount NY, Ibrahim BA, Bolaris MA, Edwards JE Jr, Swidergall M, Filler SG, Yeaman MR, Ibrahim AS.

PLoS Pathog. 2018 May 10;14(5):e1007056. doi: 10.1371/journal.ppat.1007056. eCollection 2018 May.

3.

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.

Edwards JE Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr.

Clin Infect Dis. 2018 Jun 1;66(12):1928-1936. doi: 10.1093/cid/ciy185.

PMID:
29697768
4.

Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.

Gebremariam T, Wiederhold NP, Alqarihi A, Uppuluri P, Azie N, Edwards JE Jr, Ibrahim AS.

J Antimicrob Chemother. 2017 Feb;72(2):462-466. doi: 10.1093/jac/dkw433. Epub 2016 Oct 24.

PMID:
27798213
5.

Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.

Gebremariam T, Lin L, Liu M, Kontoyiannis DP, French S, Edwards JE Jr, Filler SG, Ibrahim AS.

J Clin Invest. 2016 Jun 1;126(6):2280-94. doi: 10.1172/JCI82744. Epub 2016 May 9.

6.

Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus.

Chan LC, Chaili S, Filler SG, Barr K, Wang H, Kupferwasser D, Edwards JE Jr, Xiong YQ, Ibrahim AS, Miller LS, Schmidt CS, Hennessey JP Jr, Yeaman MR.

Infect Immun. 2015 Nov;83(11):4427-37. doi: 10.1128/IAI.01061-15. Epub 2015 Sep 8.

7.

Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine.

Liu M, Lin L, Gebremariam T, Luo G, Skory CD, French SW, Chou TF, Edwards JE Jr, Ibrahim AS.

PLoS Pathog. 2015 May 14;11(5):e1004842. doi: 10.1371/journal.ppat.1004842. eCollection 2015 May.

8.

Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Yeaman MR, Filler SG, Chaili S, Barr K, Wang H, Kupferwasser D, Hennessey JP Jr, Fu Y, Schmidt CS, Edwards JE Jr, Xiong YQ, Ibrahim AS.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5555-63. doi: 10.1073/pnas.1415610111. Epub 2014 Dec 8.

9.

Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE Jr, Hennessey JP Jr.

Front Immunol. 2014 Sep 26;5:463. doi: 10.3389/fimmu.2014.00463. eCollection 2014. Review.

10.

Isavuconazole therapy protects immunosuppressed mice from mucormycosis.

Luo G, Gebremariam T, Lee H, Edwards JE Jr, Kovanda L, Ibrahim AS.

Antimicrob Agents Chemother. 2014;58(4):2450-3. doi: 10.1128/AAC.02301-13. Epub 2014 Feb 3.

11.

CotH3 mediates fungal invasion of host cells during mucormycosis.

Gebremariam T, Liu M, Luo G, Bruno V, Phan QT, Waring AJ, Edwards JE Jr, Filler SG, Yeaman MR, Ibrahim AS.

J Clin Invest. 2014 Jan;124(1):237-50. doi: 10.1172/JCI71349. Epub 2013 Dec 20.

12.

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.

Ibrahim AS, Luo G, Gebremariam T, Lee H, Schmidt CS, Hennessey JP Jr, French SW, Yeaman MR, Filler SG, Edwards JE Jr.

Vaccine. 2013 Nov 12;31(47):5549-56. doi: 10.1016/j.vaccine.2013.09.016. Epub 2013 Sep 21.

13.

Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata.

Fu Y, Phan QT, Luo G, Solis NV, Liu Y, Cormack BP, Edwards JE Jr, Ibrahim AS, Filler SG.

Infect Immun. 2013 Jul;81(7):2528-35. doi: 10.1128/IAI.00013-13. Epub 2013 Apr 29.

14.

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE Jr, Hennessey JP Jr.

Vaccine. 2012 Dec 14;30(52):7594-600. doi: 10.1016/j.vaccine.2012.10.038. Epub 2012 Oct 22.

15.

Fungal cell wall vaccines: an update.

Edwards JE Jr.

J Med Microbiol. 2012 Jul;61(Pt 7):895-903. doi: 10.1099/jmm.0.041665-0. Epub 2012 Jan 19. Review.

16.

Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.

Luo G, Ibrahim AS, French SW, Edwards JE Jr, Fu Y.

PLoS One. 2011;6(10):e25909. doi: 10.1371/journal.pone.0025909. Epub 2011 Oct 10.

17.

Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins.

Ibrahim AS, Gebremariam T, Luo G, Fu Y, French SW, Edwards JE Jr, Spellberg B.

Antimicrob Agents Chemother. 2011 Apr;55(4):1768-70. doi: 10.1128/AAC.01577-10. Epub 2011 Jan 24.

18.

The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.

Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards JE Jr, Spellberg B.

Mol Microbiol. 2010 Aug;77(3):587-604. doi: 10.1111/j.1365-2958.2010.07234.x. Epub 2010 Jun 1.

19.

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, Edwards JE Jr, Filler SG, Ibrahim AS.

J Clin Invest. 2010 Jun;120(6):1914-24. doi: 10.1172/JCI42164. Epub 2010 May 17.

20.

The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

Infectious Diseases Society of America.

Clin Infect Dis. 2010 Apr 15;50(8):1081-3. doi: 10.1086/652237.

PMID:
20214473

Supplemental Content

Loading ...
Support Center